
PRECIDIAB National Center for Precision Diabetic Medicine
PreciDIAB National Center for Precision Diabetic Medicine is a unique collaborative venture between world-class scientists, multidisciplinary clinicians, health industry and innovative start-ups, patients and professional diabetes associations, strongly supported by national and local authorities which are all committed to achieving a simple but highly ambitious objective: to develop new solutions to control diabetes and comorbidities and to offer diabetic patients the same quality of life and longevity as non-diabetics, at reasonable costs.
PreciDIAB is unique in its kind in France
PreciDIAB is the first in class collaborative venture between Lille world-class scientists, multidisciplinary clinicians, health industry and innovative start-ups, patients and professional diabetes associations, strongly supported by national and local authorities which are all committed to achieving a simple but highly ambitious objective: to develop new solutions to control diabetes and comorbidities and to offer diabetic patients diabetes the same quality of life and longevity as non-diabetics, at reasonable costs…
A major challenge of the 21st century
Holistic analyses and clinical studies
To transform the diabetes healthcare path
Radical changes in the way health professionals are educated and trained
Most favourable conditions for efficient Public Private collaborative research
Keep up-to-date with the latest news
0
million AFFECTED
patients worldwide
0
million people with diabetes
are UNDIAGNOSED
A forecast of
0
million people affected
by 2030 is EXPECTED
NEWS


